ACAD
32.59
-0.76
-2.28%
AEMD
0.227
-0.013
-5.417%
APRI
1.87
-0.05
-2.60%
ARNA
4.37
-0.11
-2.46%
ATEC
1.45
+0.04
+2.84%
CNAT
7.12
-0.41
-5.44%
CRXM
0.195
0.00
0.00%
CYTX
1.18
-0.02
-1.67%
DXCM
62.34
+0.36
+0.58%
GNMK
12.98
-0.32
-2.41%
HALO
14.28
+0.28
+2.00%
ILMN
185.64
-1.98
-1.06%
INNV
0.14
-0.04
-21.74%
INO
8.16
-0.17
-2.04%
ISCO
0.058
-0.001
-1.1966%
ISIS
63.67
-1.14
-1.76%
LGND
77.11
+0.88
+1.15%
LPTN
2.47
0.00
0.00%
MBVX
1.87
+0.01
+0.54%
MEIP
1.79
+0.04
+2.29%
MNOV
3.5
-0.09
-2.51%
MRTX
29.32
+0.21
+0.72%
MSTX
0.485
-0.012
-2.513%
NBIX
39.71
-1.82
-4.38%
NUVA
45.99
-0.41
-0.88%
ONCS
0.335
-0.015
-4.286%
ONVO
3.54
+0.17
+5.04%
OREX
7.83
+0.08
+1.03%
OTIC
35.36
-0.27
-0.76%
QDEL
26.98
-0.52
-1.89%
RCPT
164.89
+4.84
+3.02%
RGLS
16.94
-0.32
-1.85%
RMD
71.78
+0.13
+0.18%
SCIE
0.03
0.00
+17.65%
SPHS
0.579
+0.029
+5.2545%
SRNE
11.56
+0.2
+1.76%
TROV
6.81
-0.19
-2.71%
VICL
0.945
+0.045
+4.9889%
VOLC
17.99
0.00
0.00%
ZGNX
1.37
0.00
0.00%
ACAD
32.59
-0.76
-2.28%
AEMD
0.227
-0.013
-5.417%
APRI
1.87
-0.05
-2.60%
ARNA
4.37
-0.11
-2.46%
ATEC
1.45
+0.04
+2.84%
CNAT
7.12
-0.41
-5.44%
CRXM
0.195
0.00
0.00%
CYTX
1.18
-0.02
-1.67%
DXCM
62.34
+0.36
+0.58%
GNMK
12.98
-0.32
-2.41%
HALO
14.28
+0.28
+2.00%
ILMN
185.64
-1.98
-1.06%
INNV
0.14
-0.04
-21.74%
INO
8.16
-0.17
-2.04%
ISCO
0.058
-0.001
-1.1966%
ISIS
63.67
-1.14
-1.76%
LGND
77.11
+0.88
+1.15%
LPTN
2.47
0.00
0.00%
MBVX
1.87
+0.01
+0.54%
MEIP
1.79
+0.04
+2.29%
MNOV
3.5
-0.09
-2.51%
MRTX
29.32
+0.21
+0.72%
MSTX
0.485
-0.012
-2.513%
NBIX
39.71
-1.82
-4.38%
NUVA
45.99
-0.41
-0.88%
ONCS
0.335
-0.015
-4.286%
ONVO
3.54
+0.17
+5.04%
OREX
7.83
+0.08
+1.03%
OTIC
35.36
-0.27
-0.76%
QDEL
26.98
-0.52
-1.89%
RCPT
164.89
+4.84
+3.02%
RGLS
16.94
-0.32
-1.85%
RMD
71.78
+0.13
+0.18%
SCIE
0.03
0.00
+17.65%
SPHS
0.579
+0.029
+5.2545%
SRNE
11.56
+0.2
+1.76%
TROV
6.81
-0.19
-2.71%
VICL
0.945
+0.045
+4.9889%
VOLC
17.99
0.00
0.00%
ZGNX
1.37
0.00
0.00%

Headline »

collabdrugdiscovery4

SDBN March 23rd 2015 Event: Are Collaborative Models the Path to Better San Diego Drug Discovery in 2015?

March 2, 2015 – 7:18 pm

In 2011 the San Diego Biotechnology Network (SDBN) hosted an event on “virtual” drug discovery, the then burgeoning idea that successful therapies could result from very small companies that rely on the internet-driven infrastructure to …

Read the full story »

Featured, SDBN Blog »

February SDBN Newsletter: Speed Networking Presentation, Local Events, Blogs, News, Jobs

February 7, 2015 – 10:11 am
test

Click to Read.

Read the full story »

Featured, SDBN Blog »

The Biotech/Pharma Project Manager’s Toolkit Begins January 23rd: Frequently Asked Questions (FAQ’s)

January 20, 2015 – 11:31 am
iStock_chalkboard FAQ2

We’ve been working closely with UCSD Extension to provide customized life science training that SDBN members are seeking, see our recent press release and event. Our first offering begins January 23rd, the Biotech/Pharma Project Manager’s …

Read the full story »

Featured, SDBN Blog »

First SDBN/UCSD Extension Offering To Begin January 2015: Biotech/Pharma Project Manager’s Toolkit

December 11, 2014 – 5:30 pm
15977741865_8a2162af85_m

The San Diego Biotechnology Network was formed in order to serve local life scientists, professionals and organizations and to help the region to not only grow, but thrive. Towards this end, we are working with …

Read the full story »

Breaking San Diego Biotech News

CIRM gives $25.2M to ready therapies

March 31, 2015 – 1:24 pm

Scripps Health researcher gets $7.7 million to develop knee cartilage replacement.

New Incisionless Surgery to Treat Enlarged Prostate

March 31, 2015 – 11:46 am

By age 60, more than 50 percent of men in the United States suffer from benign prostatic hyperplasia (BPH), a condition that leads to annoying changes in urinary flow. While medical therapy is usually the first line of treatment, a new m…

International Stem Cell Corporation Announces 2014 Fourth Quarter and Year-End Results

March 31, 2015 – 5:30 am

CARLSBAD, CA–(Marketwired – March 31, 2015) – International Stem Cell Corporation ( OTCQB : ISCO ) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based biotechnology company developing novel stem cell-based therapies and biom…

From Iceland to White House, Precision Medicine’s Promises & Hurdles

March 31, 2015 – 3:30 am

There is talk, and there is action. In the drive toward healthcare tailored for smaller and smaller groups of people, there was both last week, and both illustrated not just the promise of precision…

[[Click headline to continue reading.]]


See All News>>

Newest San Diego Biotech Jobs

Scientific Program Manager – Salk Institute for Biological Studies – E627

Position Description:
Incumbent will serve as project manager for preclinical and clinical research efforts including guidance, strategy and execution. Duties include but are not limited to: leadership of project team, supervision of technicians, managing pre-clinical strategies …

Clinical Trial Associate – BioPhase Solutions – San Diego, CA

We are currently looking for a Clinical Trial Associate to work for a leading San Diego biotechnology company. Bio….
From BioPhase Solutions – 01 Apr 2015 06:26:50 GMT
– View all San Diego jobs

Clinical Trial Manager – BioPhase Solutions – San Diego, CA

We are currently looking for a Clinical Trial Manager to work for a leading San Diego biotechnology company. Bio….
From BioPhase Solutions – 01 Apr 2015 06:26:49 GMT
– View all San Diego jobs

Clinical Laboratory Scientist – BioPhase Solutions – San Diego, CA

We are currently looking for a Clinical Laboratory Scientist to work for a leading San Diego biotechnology company. Bio….
From BioPhase Solutions – 01 Apr 2015 06:26:21 GMT
– View all San Diego jobs


See All Jobs>>

San Diego Biotech Blog Feed

Trilink: Liquid Biopsies Are Viewed as “Liquid Gold” for Diagnostics

Invasive Needles and Scalpels Seen as Passé Noninvasive Sampling Advocates Focusing on Circulating Tumor Cells (CTCs)  New Companies are Pursuing the Liquid Biopsy “Gold Rush” Biopsy Basics As defined in Wikipedia, a biopsy is ‘a medical test commonly performed by … Continue reading →... More...

Membrane Penetration: The Super Fins!

Hello! I am going to be writing some articles for a cool new aquatic news website called The Super Fins. Check out my first piece!  Meet the Notothenioid Fish: Antarctic Icefish Uses Antifreeze in Blood to Survive... More...

Ryon Graf: STEAM day at Muirlands Middle School

29 March 2015 About a week ago I had the honor and privilege to attend Muirlands Middle School’s STEAM career day as an invited speaker. The last time I set foot on the Muirlands campus I was a student. As I walked by the front gate I had the distinct recollection of the sound of... More...

Su Lab: What the heck is NGLY1 and why is Mark2Cure targeting it in the next campaign?

NGLY1 is the gene encoding for Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) AKA N-glycanase 1. A deficiency in this enzyme can disrupt protein quality control mechanisms in the cell, which as we’ve seen in the BioGPS Gene-of-the-week on BAG6 is very important. Learn... More...